In animals, vaspin treatment ameliorates insulin sensitivity in high-fat- or high sucrose-induced diabetes models (74) and protects against endothelial cell damage caused by free fatty acids through the PI3 kinase/Akt pathway (75). Here, SERPINA12 is linked to diabetes mellitus.